BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
135 hedge funds and large institutions have $489M invested in BioDelivery Sciences International, Inc. in 2014 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 42 increasing their positions, 34 reducing their positions, and 17 closing their positions.
124% more call options, than puts
Call options by funds: $4.32M | Put options by funds: $1.93M
118% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 17
24% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 34
16% more funds holding
Funds holding: 116 → 135 (+19)
23% less capital invested
Capital invested by funds: $639M → $489M (-$150M)
57% less funds holding in top 10
Funds holding in top 10: 7 → 3 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$12.8M |
| 2 |
State Street
Boston,
Massachusetts
|
+$12.6M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$9M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$7.97M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$7.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$10.7M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$9.12M |
| 3 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$7.64M |
| 4 |
ICRM
Insight Capital Research & Management
Walnut Creek,
California
|
-$7.47M |
| 5 |
Jane Street
New York
|
-$7.23M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
151
Tower Research Capital (TRC)
New York
| – | -$97K | -5,685 | Closed |
|
152
BNP Paribas Financial Markets
Paris,
France
| – | -$44.3K | -2,591 | Closed |
|
BDSI Hedge Fund Activity: Q4 2014 in Review
135 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q4 2014, worth a combined $489M — down 23% from $639M a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new BDSI positions and 17 closed out — a net gain of 20 holders — while 42 added to existing stakes and 34 trimmed.
The largest buyer was Frontier Capital Management, opening a new position worth an estimated $12.8M. The largest seller was Federated Hermes, cutting an estimated $10.7M.
- 135 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q4 2014, up from 116 in Q3 2014.
- Funds reported $489M of BioDelivery Sciences International, Inc. stock for Q4 2014, down 23% quarter-over-quarter.
- 37 funds opened new BioDelivery Sciences International, Inc. positions in Q4 2014 and 17 closed out, a net change of +20 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q4 2014 was Frontier Capital Management, an estimated $12.8M added.
- The largest BioDelivery Sciences International, Inc. seller in Q4 2014 was Federated Hermes, an estimated $10.7M sold.
Based on aggregated 13F filings for Q4 2014.